Healthcare stocks are attractive in a choppy market. These funds, focusing on the broader sector, drugmakers, and biotechs, ...
Biogen Inc. (NASDAQ: BIIB) is one of the 10 Most Undervalued NASDAQ Stocks to Buy Right Now. On June 29, it was reported that ...
This could be a key move for future growth.
That is a big risk investors take when trying to find the winners and losers within the biotech sector. While we made the ...
Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter: Amylyx ...
In this video, Brian T. Hill, MD, PhD, director of the Lymphoid Malignancies Program and a staff physician at the Cleveland Clinic Cancer Institute, discusses his approach for treating patients ...
Diranersen presentation will feature Phase 2 CELIA data in early Alzheimer’s disease, including clinical, biomarker and safety results for ...
Serial entrepreneur Errik Anderson's latest company is having a big 2026, signing deals with Biogen and AbbVie and raising a ...
The current health news encompasses Biogen discontinuing several Apellis programs post-acquisition, the U.S.'s active ...
Biogen discontinues Apellis programs post $5.6B acquisition, reallocating resources to Empaveli and Syfovre. U.S. begins ...
Biogen said on Friday it had either paused or discontinued funding for most of Apellis Pharmaceuticals' research programs as it integrates the rare-disease drugs specialist it purchased for $5.6 ...
Biogen is running a campaign aimed at spreading awareness of the next-gen version of its spinal muscular atrophy therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results